327
Views
14
CrossRef citations to date
0
Altmetric
BRIEF REPORT Leukemia/Lymphoma

Thrombosis in Children with Acute Lymphoblastic Leukemia Treated at a Tertiary Care Center in Lebanon: Revisiting the Role of Predictive Models

, MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 676-681 | Received 09 Mar 2011, Accepted 04 Apr 2011, Published online: 25 Jul 2011

REFERENCES

  • Athale U, Siciliano S, Thabane L, Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr Blood Cancer. 2008;51:792–797.
  • Caruso V, Iacoviello L, Di Castelnuovo A, Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108:2216–2222.
  • Payne JH, Vora AJ. Thrombosis and acute lymphoblastic leukaemia. Br J Haematol. 2007;138:430–445.
  • Mitchell L, Lambers M, Flege S, Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study. Blood. 2010;115:4999–5004.
  • Pui CH, Campana D, Pei D, Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730–2741.
  • Giordano P, Del Vecchio GC, Santoro N, Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups. Pediatr Hematol Oncol. 2000;17:667–672.
  • Giordano P, Santoro N, Del Vecchio GC, T-immunophenotype is associated with an increased prevalence of thrombosis in children with acute lymphoblastic leukemia. A retrospective study. Haematologica. 2003;88:1079–1080.
  • Athale UH, Siciliano SA, Crowther M, Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease. Br J Haematol. 2005;129:803–810.
  • Nowak-Gottl U, Ahlke E, Fleischhack G, Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood. 2003;101:2529–2533.
  • Yang L, Panetta JC, Cai X, Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J Clin Oncol. 2008;26:1932–1939.
  • Appel IM, Hop WC, van Kessel-Bakvis C, L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia. Thromb Haemost. 2008;100:330–337.
  • Boos J, Werber G, Ahlke E, Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. Eur J Cancer. 1996;32A:1544–1550.
  • Mitchell LG, Andrew M, Hanna K, A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with l-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer. 2003;97:508–516.
  • Almawi WY, Finan RR, Tamim H, Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population. Am J Hematol. 2004;76:85–87.
  • Di Minno MN, Tremoli E, Coppola A, Homocysteine and arterial thrombosis: challenge and opportunity. Thromb Haemost. 2010;103:942–961.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.